|
At least one acceptable, quality study showing effects of Category A at Dose > 1,000× Human Intake
|
At least one acceptable, quality study showing effects of Category A at Dose > 100 to < 1,000× Human Intake
|
At least one acceptable, quality study showing effects of Category A at Dose < 100× Human Intake
|
|
At least one acceptable, quality study showing effects of Category B at Dose > 100× Human Intake
|
At least one acceptable, quality study showing effects of Category B at Dose > 10 to < 100× Human Intake
|
At least one acceptable, quality study showing effects of Category B at Dose < 10× Human Intake
|
|
At least one acceptable, quality study showing effects of Category C at Dose > 10× Human Intake
OR
Studies showing adverse effects, but which cannot be interpreted because of deficiencies in design, conduct, or reporting
OR
Acceptable, quality non-oral studies indicating adverse effect from Category A, B, or C
|
At least one acceptable, quality study showing effects of Category C at Dose > 1 to < 10× Human Intake
|
At least one acceptable, quality study showing effects of Category C at Dose ≤ 1× Human Intake
|
|
a Categories A, B, and C refer to relative seriousness of a variety of adverse effects identified in animal studies, ranging from reproductive failure (A) to reduced food consumption (C). See Box 3-4 for further examples.
|